The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke
NCT ID: NCT02121327
Last Updated: 2018-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
321 participants
INTERVENTIONAL
2010-09-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke
NCT02611440
Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491
Donepezil Trial for Motor Recovery in Acute Stroke
NCT01442766
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
NCT02549846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
usual care
usual care group receive regular outpatient treatment
usual care
usual care group receive regular outpatient treatment
disease management
desease management program include self management education by nurse on 6months.
disease management
disease management program include self management education
usual care
usual care group receive regular outpatient treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
disease management
disease management program include self management education
usual care
usual care group receive regular outpatient treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving regular consultation with their primary care physician.
* modified Rankin Scale (mRS) score from 0 to 3 at discharge.
Exclusion Criteria
* Patient having severe complications and the physical symptom that the contents of the program cannot carry out.
* They had medical care in medical/nursing care institutions.
* Patients with pregnancy or under terminal care.
* Dementia (scores of ≤20/30 on the Revised Hasegawa's Dementia Scale) However, when a care-giving family member living with the patient could provide self-management, patients were included even if they had dementia.
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Labour and Welfare, Japan
OTHER_GOV
Hiroshima University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michiko Moriyama
Institute of biomedical and health sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michiko Moriyama, RN, PhD.
Role: PRINCIPAL_INVESTIGATOR
Hiroshima University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hiroshima University
Hiroshima, Hiroshima, Japan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Crocker TF, Brown L, Lam N, Wray F, Knapp P, Forster A. Information provision for stroke survivors and their carers. Cochrane Database Syst Rev. 2021 Nov 23;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4.
Fukuoka Y, Hosomi N, Hyakuta T, Omori T, Ito Y, Uemura J, Yagita Y, Kimura K, Matsumoto M, Moriyama M; for DMP Stroke Trial Investigators. Effects of a Disease Management Program for Preventing Recurrent Ischemic Stroke. Stroke. 2019 Mar;50(3):705-712. doi: 10.1161/STROKEAHA.118.020888.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21171401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.